Corrigendum: Discovery of spirooxindole-derived small-molecule compounds as novel HDAC/MDM2 dual inhibitors and investigation of their anticancer activity

Corrigendum: Discovery of spirooxindole-derived small-molecule compounds as novel HDAC/MDM2 dual inhibitors and investigation of their anticancer activity

Bibliographic Details
Main Authors:	Qian Zhao, Shan-Shan Xiong, Can Chen, Hong-Ping Zhu, Xin Xie, Cheng Peng, Gu He, Bo Han
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-08-01
Series:	Frontiers in Oncology
Subjects:	multitarget drugs histone deacetylase inhibitors MDM2 inhibitors spirooxindole dual inhibitors anticancer
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1259550/full

Similar Items

Discovery of spirooxindole-derived small-molecule compounds as novel HDAC/MDM2 dual inhibitors and investigation of their anticancer activity
by: Qian Zhao, et al.
Published: (2022-08-01)

Anticancer Therapy with HDAC Inhibitors: Mechanism-Based Combination Strategies and Future Perspectives
by: Robert Jenke, et al.
Published: (2021-02-01)

Discovery of indole-3-butyric acid derivatives as potent histone deacetylase inhibitors
by: Yiming Chen, et al.
Published: (2021-01-01)

The Role of HDACs as Leukemia Therapy Targets using HDI
by: Ahmad Ahmadzadeh, et al.
Published: (2016-02-01)

Activation of p53 signaling and regression of breast and prostate carcinoma cells by spirooxindole-benzimidazole small molecules
by: Assem Barakat, et al.
Published: (2024-04-01)

Improved Anticancer Activities of a New Pentafluorothio-Substituted Vorinostat-Type Histone Deacetylase Inhibitor
by: Nils Goehringer, et al.
Published: (2021-12-01)

Discovery of potent histone deacetylase inhibitors with modified phenanthridine caps
by: Wenli Fan, et al.
Published: (2021-01-01)

HDAC Inhibitors for the Therapy of Triple Negative Breast Cancer
by: Cristina Maccallini, et al.
Published: (2022-05-01)

Rational drug design, synthesis, and biological evaluation of novel chiral tetrahydronaphthalene-fused spirooxindole as MDM2-CDK4 dual inhibitor against glioblastoma
by: Biao Wang, et al.
Published: (2020-08-01)

Correlation Analysis of Protein Expression of 10 HDAC/Sirtuin Isoenzymes with Sensitivities of 23 Anticancer Drugs in 17 Cancer Cell Lines and Potentiation of Drug Activity by Co-Treatment with HDAC Inhibitors
by: Steven Behnisch-Cornwell, et al.
Published: (2021-12-01)

Small Molecules Targeting HATs, HDACs, and BRDs in Cancer Therapy
by: Donglu Wu, et al.
Published: (2020-11-01)

Synthesis, Antiplasmodial, and Antileukemia Activity of Dihydroartemisinin–HDAC Inhibitor Hybrids as Multitarget Drugs
by: Lukas von Bredow, et al.
Published: (2022-03-01)

Anticancer Ruthenium Complexes with HDAC Isoform Selectivity
by: Jasmine M. Cross, et al.
Published: (2020-05-01)

Roles of Histone Deacetylases and Inhibitors in Anticancer Therapy
by: Flávia Alves Verza, et al.
Published: (2020-06-01)

Inhibiting Histone Deacetylase 2 (HDAC2) Promotes Functional Recovery From Stroke
by: Ying Tang, et al.
Published: (2017-10-01)

Discovery and SAR analysis of 5-chloro-4-((substituted phenyl)amino)pyrimidine bearing histone deacetylase inhibitors
by: Lin Zhang, et al.
Published: (2022-12-01)

Discovery of 2-Phenylquinoline-4-Carboxylic Acid Derivatives as Novel Histone Deacetylase Inhibitors
by: Qian Hui, et al.
Published: (2022-07-01)

Introducing HDAC-Targeting Radiopharmaceuticals for Glioblastoma Imaging and Therapy
by: Liesbeth Everix, et al.
Published: (2023-02-01)

Exploration of quinazoline-tethered hydroxamic acid derivatives as HDAC inhibitors for anticancer activity: Design, synthesis, molecular docking, and biological evaluation
by: Shweta Mishra, et al.
Published: (2024-01-01)

Discovery of BRAF/HDAC Dual Inhibitors Suppressing Proliferation of Human Colorectal Cancer Cells
by: Yingjun Li, et al.
Published: (2022-07-01)

Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various Cancers
by: Masumeh Sanaei, et al.
Published: (2019-01-01)

The Emerging Role of HDACs: Pathology and Therapeutic Targets in Diabetes Mellitus
by: Saikat Dewanjee, et al.
Published: (2021-05-01)

Editorial: Recent advances in the research and development of kinase-inhibitory anticancer molecules
by: Ahmed A. Al-Karmalawy, et al.
Published: (2023-11-01)

Screening of selective histone deacetylase inhibitors by proteochemometric modeling
by: Wu Dingfeng, et al.
Published: (2012-08-01)

Discovery of novel polysubstituted N-alkyl acridone analogues as histone deacetylase isoform-selective inhibitors for cancer therapy
by: Ze Wang, et al.
Published: (2023-12-01)

HAT- and HDAC-Targeted Protein Acetylation in the Occurrence and Treatment of Epilepsy
by: Jie Wang, et al.
Published: (2022-12-01)

Anticancer Activity and Mechanisms of Action of New Chimeric EGFR/HDAC-Inhibitors
by: Nils Goehringer, et al.
Published: (2021-08-01)

Recent Small-Molecule Inhibitors of the p53–MDM2 Protein–Protein Interaction
by: Anastasia Beloglazkina, et al.
Published: (2020-03-01)

Tetrahydroisoquinolines as novel histone deacetylase inhibitors for treatment of cancer
by: Danqi Chen, et al.
Published: (2016-01-01)

Advanced Progress of Histone Deacetylases in Rheumatic Diseases
by: Liu XM, et al.
Published: (2024-02-01)

Epigenetic modulation of immunotherapy cofactors to enhance tumor response in lung cancer
by: Anuhya Kommalapati, et al.
Published: (2021-01-01)

Molecular Docking Simulations on Histone Deacetylases (HDAC)-1 and -2 to Investigate the Flavone Binding
by: Bernardina Scafuri, et al.
Published: (2020-12-01)

Effects of HDAC inhibitors on spatial memory and memory extinction in SPS-induced PTSD rats
by: Ahmad Mohammadi-Farani, et al.
Published: (2020-01-01)

Select HDAC Inhibitors Enhance Osteolysis and Bone Metastasis Outgrowth but Can Be Mitigated With Bisphosphonate Therapy
by: Miranda E Clements, et al.
Published: (2023-03-01)

Histone deacetylase inhibitors
by: Marzena Baran, et al.
Published: (2020-08-01)

Targeting the Interplay between HDACs and DNA Damage Repair for Myeloma Therapy
by: Maria Gkotzamanidou, et al.
Published: (2021-09-01)

The Roles of Histone Deacetylases in the Regulation of Ovarian Cancer Metastasis
by: Long Xu, et al.
Published: (2023-10-01)

Histone Deacetylases and Their Isoform-Specific Inhibitors in Ischemic Stroke
by: Svetlana Demyanenko, et al.
Published: (2021-10-01)

Histone Deacetylase Functions in Gastric Cancer: Therapeutic Target?
by: Amandine Badie, et al.
Published: (2022-11-01)

Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro
by: Kim Freese, et al.
Published: (2019-10-01)